New appointments at Cell Medica
This article was originally published in Scrip
Executive Summary
Cell Medica, a UK clinical-stage cellular therapeutics company focused on the development and delivery of cellular immunotherapy treatment strategies for infectious disease and cancer, has made the following appointments: Dr Rainer Knaus, who has more than 10 years' experience in the GMP manufacturing of cell therapies, as senior vice-president; Mike Ramsay, formerly senior vice-president of operations at Cell Genesys, as head of US operations; Karen Hodgkin, who has 25 years' experience in clinical trials management, as head of clinical development; and Tina Crombie as head of business administration.